New drug shows promise for rare nerve tumors in chinese patients
NCT ID NCT04590235
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 27 times
Summary
This early-stage study tests a drug called selumetinib in 32 Chinese children and adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be surgically removed. The main goals are to check the drug's safety and how the body processes it, while also measuring if the tumors shrink. Participants take the drug by mouth and are monitored for side effects and tumor changes using MRI scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Shanghai, 200011, China
-
Research Site
Shanghai, CN-200092, China
Conditions
Explore the condition pages connected to this study.